Delivery Order SPE2DB20D3505-SPE2DB23FU7V3
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,184.68, is for the delivery of the MENVEO A-C-Y-W KIT (2 VIALS) medical product, which is a vaccine. The contract has a completion date of May 18, 2023 and is structured as a firm fixed-price Delivery Order. The contract was not designated with a set-aside requirement, indicating it was awarded through full and open...
- This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,023.35, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price, and the ultimate completion date is November 7, 2023. This award is not associated with a set-aside designation,...
- This federal contract award is for the delivery of MENVEO A-C-Y-W-135-DIP VIAL KTS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,024.34 and is a Firm Fixed Price Delivery Order with a completion date of June 2, 2022. There is no set-aside designation, indicating the contract was awarded through full and open...
- This federal contract award is for the delivery of Menveo A-C-Y-W Kits (2 vials) to the Defense Logistics Agency (DLA). The contract, valued at $1,542.20, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs...
- This federal contract award is for the delivery of the MENVEO A-C-Y-W KIT (2 VIALS), a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 7, 2023, with a ceiling value of $1,777.02 and a completion date of June 8, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award is for the delivery of MENVEO A-C-Y-W kits to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, which is a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $3,545.50 and a completion date of July 6, 2023. It is a firm fixed-price delivery order contract awarded on July 5, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is...
- This federal contract award is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS) medical supplies, valued at $1,734.15. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order, with a firm fixed price pricing type and an ultimate completion date of August 22, 2024. This contract award is not associated with a set-aside program. Amerisourcebergen Drug Corp has extensive...
- This federal contract award is for the delivery of MENVEO A-C-Y-W-135-DIP VIAL KTS, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $8,434.75 and an ultimate completion date of July 21, 2022. It is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $70,908.00, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and a completion date of September 6, 2023. The award was not designated with a set-aside requirement. Amerisourcebergen Drug Corp is a...
- This federal contract award is for the delivery of MENVEO A-C-Y-W vaccine kits to the Defense Logistics Agency (DLA). The contract, valued at $1,286.76, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 6, 2024. The contract has a firm fixed price and an ultimate completion date of November 7, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FU7V3Delivery Order
This federal contract award is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS) to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $3,161.25 and an ultimate completion date of September 25, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating it was issued through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/22/23 |